{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and posted_year = 2010 sorted by posted_date descending", "rows": [["FDA-2010-E-0662-0001", "FDA", "FDA-2010-E-0662", "Aventis Pharma S.A. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:23Z", null, 0, 0, "0900006480bc2a98"], ["FDA-2010-N-0118-0005", "FDA", "FDA-2010-N-0118", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Imported Food under 2002 Public Health Security and Bioterrorism Preparedness and Response Act of 2002", "Notice", "N-Notice", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T14:44:54Z", "2010-32946", 0, 0, "0900006480bc26ef"], ["FDA-1997-N-0020-0047", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:38Z", null, 0, 0, "0900006480bc1cde"], ["FDA-2010-N-0356-0004", "FDA", "FDA-2010-N-0356", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Designated New Animal Drugs for Minor Use and Minor Species", "Notice", "N-Notice", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T14:39:28Z", "2010-32948", 0, 0, "0900006480bc26eb"], ["FDA-2010-E-0656-0001", "FDA", "FDA-2010-E-0656", "Amgen Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-08-11T04:43:36Z", null, 0, 0, "0900006480bc285b"], ["FDA-1997-N-0020-0034", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:15Z", null, 0, 0, "0900006480bc0e46"], ["FDA-1997-N-0020-0022", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:19:54Z", null, 0, 0, "0900006480bc0dca"], ["FDA-1997-N-0020-0038", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:22Z", null, 0, 0, "0900006480bc1ae6"], ["FDA-2010-E-0656-0003", "FDA", "FDA-2010-E-0656", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T16:57:57Z", null, 0, 0, "0900006480bc28a7"], ["FDA-2010-E-0659-0001", "FDA", "FDA-2010-E-0659", "Amgen Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:21Z", null, 0, 0, "0900006480bc28b0"], ["FDA-1997-N-0020-0024", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:19:58Z", null, 0, 0, "0900006480bc0dcc"], ["FDA-1997-N-0020-0025", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:19:59Z", null, 0, 0, "0900006480bc0dd0"], ["FDA-1997-N-0020-0029", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:07Z", null, 0, 0, "0900006480bc0e41"], ["FDA-1997-N-0020-0035", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:17Z", null, 0, 0, "0900006480bc0e47"], ["FDA-2010-E-0662-0002", "FDA", "FDA-2010-E-0662", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-08-11T01:39:02Z", null, 0, 0, "0900006480bc2a9a"], ["FDA-2010-E-0661-0002", "FDA", "FDA-2010-E-0661", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:23Z", null, 0, 0, "0900006480bc2a28"], ["FDA-1997-N-0020-0023", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:19:56Z", null, 0, 0, "0900006480bc0dcb"], ["FDA-1997-N-0020-0044", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:33Z", null, 0, 0, "0900006480bc1cd8"], ["FDA-2010-E-0656-0002", "FDA", "FDA-2010-E-0656", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:21Z", null, 0, 0, "0900006480bc285c"], ["FDA-1997-N-0020-0030", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:08Z", null, 0, 0, "0900006480bc0e42"], ["FDA-1997-N-0020-0039", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:24Z", null, 0, 0, "0900006480bc1ae7"], ["FDA-1997-N-0020-0043", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:31Z", null, 0, 0, "0900006480bc1cd6"], ["FDA-1997-N-0020-0028", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:05Z", null, 0, 0, "0900006480bc0e40"], ["FDA-1997-N-0020-0046", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:37Z", null, 0, 0, "0900006480bc1cda"], ["FDA-1997-N-0020-0049", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:42Z", null, 0, 0, "0900006480bc210a"], ["FDA-1997-N-0020-0036", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:19Z", null, 0, 0, "0900006480bc0e6a"], ["FDA-2010-E-0657-0002", "FDA", "FDA-2010-E-0657", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T18:00:32Z", null, 0, 0, "0900006480bc28ab"], ["FDA-2010-E-0657-0001", "FDA", "FDA-2010-E-0657", "Amgen Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-08-11T01:39:02Z", null, 0, 0, "0900006480bc28a9"], ["FDA-1997-N-0020-0048", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:40Z", null, 0, 0, "0900006480bc2109"], ["FDA-1997-N-0020-0027", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:03Z", null, 0, 0, "0900006480bc0e3f"], ["FDA-1997-N-0020-0037", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:21Z", null, 0, 0, "0900006480bc0e6b"], ["FDA-1997-N-0020-0026", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:01Z", null, 0, 0, "0900006480bc0e3e"], ["FDA-2010-E-0657-0003", "FDA", "FDA-2010-E-0657", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2010-12-30T18:00:33Z", null, 0, 0, "0900006480bc28ae"], ["FDA-2010-E-0659-0003", "FDA", "FDA-2010-E-0659", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:22Z", null, 0, 0, "0900006480bc29ce"], ["FDA-2010-E-0663-0002", "FDA", "FDA-2010-E-0663", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-08-11T04:43:37Z", null, 0, 0, "0900006480bc2a9e"], ["FDA-2010-E-0663-0001", "FDA", "FDA-2010-E-0663", "Danek, et al. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:23Z", null, 0, 0, "0900006480bc2a9c"], ["FDA-1997-N-0020-0042", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:30Z", null, 0, 0, "0900006480bc1b4e"], ["FDA-1997-N-0020-0031", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:10Z", null, 0, 0, "0900006480bc0e43"], ["FDA-1997-N-0020-0032", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:12Z", null, 0, 0, "0900006480bc0e44"], ["FDA-1997-N-0020-0040", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:26Z", null, 0, 0, "0900006480bc1b4a"], ["FDA-1997-N-0020-0045", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:35Z", null, 0, 0, "0900006480bc1cd9"], ["FDA-1997-N-0020-0041", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:28Z", null, 0, 0, "0900006480bc1b4d"], ["FDA-1997-N-0020-0033", "FDA", "FDA-1997-N-0020", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2010-12-30T05:00:00Z", 2010, 12, null, null, "2010-12-30T13:20:14Z", null, 0, 0, "0900006480bc0e45"], ["FDA-2010-E-0659-0002", "FDA", "FDA-2010-E-0659", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:22Z", null, 0, 0, "0900006480bc29cc"], ["FDA-2010-E-0661-0001", "FDA", "FDA-2010-E-0661", "Aventis Pharma S.A. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-30T05:00:00Z", 2010, 12, "2010-12-30T05:00:00Z", null, "2013-07-27T23:41:23Z", null, 0, 0, "0900006480bc2a24"], ["FDA-2010-E-0653-0001", "FDA", "FDA-2010-E-0653", "Gilead Sciences, Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:14Z", null, 0, 0, "0900006480bc1ee3"], ["FDA-2008-E-0266-0008", "FDA", "FDA-2008-E-0266", "U.S. Patent and Trademark Office to Johnson & Johnson - Notice of Final Determination Letter", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:14Z", null, 0, 0, "0900006480bc1ecf"], ["FDA-1978-N-0021-0034", "FDA", "FDA-1978-N-0021", "Attachment 2 - FDA Alert (12/11/2008)  [FDA-1978-N-0021-0032]", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2010-12-29T19:21:54Z", null, 0, 0, "0900006480bc2184"], ["FDA-2010-E-0653-0002", "FDA", "FDA-2010-E-0653", "U.S. Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:14Z", null, 0, 0, "0900006480bc1ee5"], ["FDA-2010-N-0001-0163", "FDA", "FDA-2010-N-0001", "Meetings: Pulmonary-Allergy Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2010-12-29T15:23:00Z", "2010-32735", 0, 0, "0900006480bc1b9a"], ["FDA-1997-N-0020-0018", "FDA", "FDA-1997-N-0020", "Reference 3 - Memorandum for the Heads of Executive Departments and Agencies, June 1, 1998, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:47:06Z", null, 0, 0, "0900006480bc13ac"], ["FDA-1978-N-0021-0035", "FDA", "FDA-1978-N-0021", "Attachment 3 - FDA Alert (5/2006)  [FDA-1978-N-0021-0032]", "Supporting & Related Material", "BKG-Background Material", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2010-12-29T19:30:50Z", null, 0, 0, "0900006480bc2187"], ["FDA-2010-E-0654-0002", "FDA", "FDA-2010-E-0654", "U.S Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:17Z", null, 0, 0, "0900006480bc2342"], ["FDA-2010-E-0655-0002", "FDA", "FDA-2010-E-0655", "U.S Patent and Trademark Office to FDA - Letter", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:17Z", null, 0, 0, "0900006480bc2344"], ["FDA-1997-N-0020-0015", "FDA", "FDA-1997-N-0020", "Index of Background Material re Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:42:44Z", null, 0, 0, "0900006480bc0bea"], ["FDA-1997-N-0020-0014", "FDA", "FDA-1997-N-0020", "FDA/CFSAN to the Division of Dockets Management, February 6, 2006", "Other", "Memorandum", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2011-10-26T21:51:50Z", null, 0, 0, "0900006480bc0beb"], ["FDA-1997-N-0020-0021", "FDA", "FDA-1997-N-0020", "Reference 6 - Guidance for Industry: Frequently Asked Questions About GRAS, December 2004, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:48:28Z", null, 0, 0, "0900006480bc13da"], ["FDA-1978-N-0021-0033", "FDA", "FDA-1978-N-0021", "Attachment 1 - Letter to Peter S. Reichertz, Esq [FDA-1978-N-0021-0032]", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2010-12-29T19:16:08Z", null, 0, 0, "0900006480bc2182"], ["FDA-1997-N-0020-0020", "FDA", "FDA-1997-N-0020", "Reference 5 - Nanotechnology Task Force Report 2007, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:48:05Z", null, 0, 0, "0900006480bc13d9"], ["FDA-1997-N-0020-0016", "FDA", "FDA-1997-N-0020", "Reference 1 - Experience With GRAS Notices Under the 1997 Proposed Rule, November 4, 2010, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:45:51Z", null, 0, 0, "0900006480bc0bec"], ["FDA-1978-N-0021-0032", "FDA", "FDA-1978-N-0021", "Letter from FDA/CDER to Peter S. Reichertz, Esq. and Christopher A. Brown, Esq.", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2016-09-13T15:18:53Z", null, 0, 0, "0900006480bc2181"], ["FDA-2010-E-0654-0001", "FDA", "FDA-2010-E-0654", "Gilead Sciences, Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-07-27T23:41:17Z", null, 0, 0, "0900006480bc225b"], ["FDA-2010-E-0655-0001", "FDA", "FDA-2010-E-0655", "Gilead Sciences, Inc. - Patent Term Extension Application", "Other", "APP-Application", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2013-08-11T03:12:28Z", null, 0, 0, "0900006480bc2343"], ["FDA-1978-N-0021-0036", "FDA", "FDA-1978-N-0021", "Attachment 4 - Science Backgrounder: Safethy of Sodium Phosphates Oral Solution  [FDA-1978-N-0021-0032]", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2010-12-29T19:35:46Z", null, 0, 0, "0900006480bc226a"], ["FDA-2010-N-0640-0001", "FDA", "FDA-2010-N-0640", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Data To Support Food and Nutrition Product Communications, as Used by Food and Drug Administration", "Notice", "N-Notice", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", "2011-03-01T04:59:59Z", "2010-12-29T15:29:12Z", "2010-32739", 0, 0, "0900006480bc1bc0"], ["FDA-1997-N-0020-0019", "FDA", "FDA-1997-N-0020", "Reference 4 - Notification for New Use of a Food Contact Substance, FDA Form No. 3480, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:47:37Z", null, 0, 0, "0900006480bc13ad"], ["FDA-1997-N-0020-0017", "FDA", "FDA-1997-N-0020", "Reference 2 - GAO, FDA Should Strengthen Its Oversight of Food Ingredients Determinationed to Be Generally Recognized as Safe (GRAS) Report No. GAO-10-246, February 2010, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013", "Supporting & Related Material", "Reference (internal unless indicated)", "2010-12-29T05:00:00Z", 2010, 12, null, null, "2011-10-26T21:46:25Z", null, 0, 0, "0900006480bc13ab"], ["FDA-2010-N-0511-0003", "FDA", "FDA-2010-N-0511", "FDA/DDM Letter to Division of Wyeth Holdings - Letter", "Other", "LET-Letter", "2010-12-29T05:00:00Z", 2010, 12, "2010-12-29T05:00:00Z", null, "2010-12-29T14:34:06Z", null, 0, 0, "0900006480bc1b46"], ["FDA-2010-N-0198-0003", "FDA", "FDA-2010-N-0198", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:44:38Z", "2010-32508", 0, 0, "0900006480bc11ca"], ["FDA-2010-P-0326-0003", "FDA", "FDA-2010-P-0326", "Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TRANDATE (Labetalol Hydrochloride) Tablets, 300 Milligrams and 400 Milligrams", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:37:57Z", "2010-32507", 0, 0, "0900006480bc11ac"], ["FDA-2008-E-0261-0008", "FDA", "FDA-2008-E-0261", "U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination", "Other", "LET-Letter", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2013-07-27T23:40:43Z", null, 0, 0, "0900006480bc0e70"], ["FDA-2010-N-0002-0088", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Deslorelin", "Rule", "NFR-Notice of Final Rule", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T15:43:43Z", "2010-32554", 0, 0, "0900006480bc0c09"], ["FDA-2009-E-0014-0007", "FDA", "FDA-2009-E-0014", "U.S. Patent & Trademark Office to Abbott Diabetes Care Inc. - Letter with enclosure", "Other", "LET-Letter", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2013-07-27T23:40:43Z", null, 0, 0, "0900006480bc0e15"], ["FDA-2010-N-0001-0161", "FDA", "FDA-2010-N-0001", "Meetings: Anesthetic and Life Support Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:11:53Z", "2010-32591", 0, 0, "0900006480bc0c47"], ["FDA-2008-E-0258-0008", "FDA", "FDA-2008-E-0258", "U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination", "Other", "LET-Letter", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2013-07-27T23:40:43Z", null, 0, 0, "0900006480bc0e6e"], ["FDA-2008-E-0260-0008", "FDA", "FDA-2008-E-0260", "U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination", "Other", "LET-Letter", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2013-08-11T03:12:26Z", null, 0, 0, "0900006480bc0e72"], ["FDA-2010-N-0002-0089", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares", "Other", "FOIS-Freedom of Information Summary (No Federal Register Publication)", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:01:31Z", null, 0, 0, "0900006480bc13dc"], ["FDA-2010-N-0001-0162", "FDA", "FDA-2010-N-0001", "Request for Nominations: Voting and Non-Voting Members of Public Advisory Committees or Panels", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:28:32Z", "2010-32624", 0, 0, "0900006480bc1153"], ["FDA-2010-N-0447-0003", "FDA", "FDA-2010-N-0447", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Third Party Review Program Under the Food and Drug Administration Modernization Act", "Notice", "N-Notice", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2011-03-14T20:37:01Z", "2010-32603", 0, 0, "0900006480bc0c82"], ["FDA-1997-N-0020-0013", "FDA", "FDA-1997-N-0020", "Substances Generally Recognized as Safe; Reopening of the Comment", "Proposed Rule", "Reopening of Comment Period", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", "2011-03-29T03:59:59Z", "2016-09-29T01:00:28Z", "2010-32344", 0, 0, "0900006480bc0c0f"], ["FDA-2010-N-0511-0002", "FDA", "FDA-2010-N-0511", "FDA/DDM Letter to Division of Wyeth Holdings - Letter", "Other", null, "2010-12-28T00:00:00Z", 2010, 12, null, null, "2010-12-29T14:18:57Z", null, 0, 1, "0900006480b77e4c"], ["FDA-2010-N-0001-0160", "FDA", "FDA-2010-N-0001", "Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2010-12-27T14:48:01Z", "2010-32367", 0, 0, "0900006480bc03c3"], ["FDA-2010-P-0630-0009", "FDA", "FDA-2010-P-0630", "Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Correction", "Other", "Correction(s)", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2012-05-09T22:38:35Z", null, 0, 0, "0900006480bbd326"], ["FDA-2010-E-0037-0007", "FDA", "FDA-2010-E-0037", "U.S. Patent & Trademark Office to FDA/CDER - Letter with enclosure", "Other", "LET-Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-07-27T23:40:38Z", null, 0, 0, "0900006480bc087d"], ["FDA-2010-N-0001-0159", "FDA", "FDA-2010-N-0001", "Oncologic Drugs Advisory Committee; Cancellation", "Notice", "N-Notice", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2010-12-27T14:44:55Z", "2010-32413", 0, 0, "0900006480bc0306"], ["FDA-2010-P-0630-0008", "FDA", "FDA-2010-P-0630", "Attachment XII - \"Jekat, F. et al. IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids - Heyltex Corporation - [HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:31:41Z", null, 0, 0, "0900006480bb3e08"], ["FDA-2010-P-0628-0004", "FDA", "FDA-2010-P-0628", "Attachment I - \"Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:14:05Z", null, 0, 0, "0900006480bb2c17"], ["FDA-2010-P-0630-0006", "FDA", "FDA-2010-P-0630", "Attachment VI - \"Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements\" - Heyltex Corporation - [HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:29:18Z", null, 0, 0, "0900006480bb3df7"], ["FDA-2010-P-0628-0006", "FDA", "FDA-2010-P-0628", "Attachment V - Breustedt, B. et al, \"Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:18:35Z", null, 0, 0, "0900006480bb30db"], ["FDA-2010-P-0628-0007", "FDA", "FDA-2010-P-0628", "Attachment VII - \"Mayak Worker Study Project 2.4 Volume III Internal Dosimetry Dose Reconstruction Methods Used in Preparation of Doses-2005 Database\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:19:56Z", null, 0, 0, "0900006480bb30de"], ["FDA-2009-E-0020-0009", "FDA", "FDA-2009-E-0020", "U.S. Patent & Trademark Office to  Millen, White, Zelano & Branigan, P.C. - Notice of Final Determinaton", "Other", "LET-Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-08-11T03:12:25Z", null, 0, 0, "0900006480bc0880"], ["FDA-2004-E-0266-0009", "FDA", "FDA-2004-E-0266", "U.S. Patent & Trademark Office to  Connolly Bove Lodge & Hutz LLP - Notice of Final Determinaton", "Other", "LET-Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-07-27T23:40:38Z", null, 0, 0, "0900006480bc087f"], ["FDA-2010-P-0582-0005", "FDA", "FDA-2010-P-0582", "Acknowledgement Letter to Lachman Consultant Services, Inc.", "Other", "ACK-Acknowledgement Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-07-27T23:37:21Z", null, 0, 0, "0900006480b8a212"], ["FDA-2010-P-0582-0003", "FDA", "FDA-2010-P-0582", "Attachment 2 - \"Description Information, Mercaptopurine Tablets, USP\" - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T18:31:36Z", null, 0, 0, "0900006480b8a0c0"], ["FDA-2010-P-0628-0005", "FDA", "FDA-2010-P-0628", "Attachment II - \"Federal Register/ Vol. 68, No. 178/ Monday, September 15, 2003/Notice\" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:16:46Z", null, 0, 0, "0900006480bb2c18"], ["FDA-2007-E-0048-0008", "FDA", "FDA-2007-E-0048", "U.S. Patent & Trademark Office to Harness, Dickey & Pierce, PLC  - Notice of Final Determinaton", "Other", "LET-Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-08-11T01:38:57Z", null, 0, 0, "0900006480bc0881"], ["FDA-2010-P-0628-0008", "FDA", "FDA-2010-P-0628", "Attachment XI - \"IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids\" Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T19:36:22Z", null, 0, 0, "0900006480bb30e2"], ["FDA-2010-P-0582-0002", "FDA", "FDA-2010-P-0582", "Attachment 1 \"Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations\" - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T18:31:35Z", null, 0, 0, "0900006480b8a0bf"], ["FDA-2010-P-0582-0004", "FDA", "FDA-2010-P-0582", "Attachment 3 - \"Description Information, Purinethol - Mercaptopurine Tablets, Gate Pharmaceuticals\" - [Lachman Consultant Services, Inc. - Citizen Petition]", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2010-12-27T05:00:00Z", 2010, 12, null, null, "2010-12-27T18:31:38Z", null, 0, 0, "0900006480b8a15d"], ["FDA-2010-V-0587-0002", "FDA", "FDA-2010-V-0587", "Acknowledgement Letter to Syndicate Hospitality Group", "Other", "ACK-Acknowledgement Letter", "2010-12-27T05:00:00Z", 2010, 12, "2010-12-27T05:00:00Z", null, "2013-07-27T23:37:31Z", null, 0, 0, "0900006480b93263"]], "truncated": false, "filtered_table_rows_count": 3813, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "2010"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2010", "results": [{"value": "FDA", "label": "FDA", "count": 3813, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?posted_year=2010", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2010", "results": [{"value": "Other", "label": "Other", "count": 1967, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 921, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 797, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&document_type=Notice", "selected": false}, {"value": "Rule", "label": "Rule", "count": 87, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&document_type=Rule", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 41, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2010", "results": [{"value": 2010, "label": 2010, "count": 3813, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_facet_date=last_modified"}], "next": "2010-12-27T05~3A00~3A00Z,FDA-2010-V-0587-0002", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010&_next=2010-12-27T05~3A00~3A00Z%2CFDA-2010-V-0587-0002&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1848.6047741025686, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}